To demonstrate the role of GSK3β in regulating Fbxo4-mediated Fxr1 degradation, SB-216763 was utilised to treat HNSCC cells with or without ectopic Fbxo4 expression. This evidence concerns the gene FXR1 and head and neck squamous cell carcinoma.